Fruergaard leveraging experience from Danish partnerships in key roles in Brussels
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.
BY PETER THOMSEN, WATCH MEDIERS EU-KORRESPONDENT, TRANSLATED BY CHRISTOFFER ØSTERGAARD
Brussels – There will be Danish roots to be found in the life science sector’s undertakings in Brussels over the next year.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
European pharma strategy report approved with huge majority
For subscribers
New EU portal for clinical trials launches on Monday
For subscribers
.jpg&w=384&q=75)
